Table of Contents PART 01: Executive summary • Highlights PART 02: Scope of the report • Market overview • Top-vendor offerings PART 03: Market research methodology • Research methodology • Economic indicators PART 04: Introduction • Key market highlights PART 05: Regulatory scenario of vaccines PART 06: Market landscape • Market overview • Five forces analysis PART 07: Market segmentation by disease type PART 08: Market segmentation by composition • Mono vaccines • Combination vaccines PART 09: Geographical segmentation • Travel vaccines market in Americas • Travel vaccines market in EMEA • Travel vaccines market in APAC PART 10: Market drivers • Growing demand among travelers • Additional age group approval • Inclusion in NIP PART 11: Impact of drivers PART 12: Market challenges • Requires specific storage and distribution system • High risk and cost involved in vaccine development • Stringent regulatory guidelines PART 13: Impact of drivers and challenges PART 14: Market trends • Combination vaccines • Increase in R&D activities • Public–private initiatives PART 15: Vendor landscape • Competitive scenario • Other prominent vendors PART 16: Key vendor analysis • GlaxoSmithKline • Merck • Pfizer • Sanofi PART 17: Appendix • List of abbreviations PART 18: Explore Technavio List of Exhibits Exhibit 01: Product offerings Exhibit 02: Market share of travel vaccines markets in global pharmaceutical market 2015 Exhibit 03: Market share of travel vaccines markets in global pharmaceutical market, 2015 Exhibit 04: Country/region-specific vaccination Exhibit 05: Key buying criteria for travel vaccines 2015 Exhibit 06: Impact of key customer segments on market 2015 Exhibit 07: Requirements for a BLA submission Exhibit 08: Stages of vaccine development to obtain license Exhibit 09: Processes involved in the vaccine development Exhibit 10: Regulatory testing of licensed vaccines Exhibit 11: Market snapshot: Global travel vaccines market Exhibit 12: Worldwide endemicity of HAV infection Exhibit 13: Endemicity pattern of HBV across various regions Exhibit 14: Global travel vaccine market snapshot: Developed and emerging markets 2015 Exhibit 15: Overview of vaccine-related acquisitions (2005-2012) Exhibit 16: Global travel vaccines market 2015-2020 ($ billions) Exhibit 17: Few of approved travel vaccines Exhibit 18: Vaccine recommendation for travelers Exhibit 19: Five forces analysis Exhibit 20: Market segmentation of travel vaccines based on disease type 2015 Exhibit 21: Market share of the different types of travel vaccines based on disease type 2015 Exhibit 22: Overview of global travel vaccines market segmentation based on disease type 2015-2020 Exhibit 23: Global travel vaccines market segmentation by composition Exhibit 24: Details of approved polysaccharide vaccines Exhibit 25: Snapshot of global travel vaccines market by geography 2015-2020 Exhibit 26: Global travel vaccines market segmentation by geography 2015-2020 ($ millions) Exhibit 27: Overview of travel vaccines market in Americas Exhibit 28: Recommended vaccination for travelers to Mexico Exhibit 29: Recommended vaccination for travelers to Brazil Exhibit 30: Travel vaccines market in Americas 2015-2020 ($ billions) Exhibit 31: Overview of travel vaccines market in EMEA Exhibit 32: Outbreaks of measles in EMEA during 2011 Exhibit 33: Recommended vaccination for travelers to Italy Exhibit 34: Recommended vaccinations for travelers to France Exhibit 35: Recommended vaccinations for some travelers to South Africa Exhibit 36: Travel vaccines market in EMEA 2015-2020 ($ millions) Exhibit 37: Overview of travel vaccines market in APAC Exhibit 38: Recommended vaccination for travelers to India Exhibit 39: Recommended vaccination for travelers to China Exhibit 40: Travel vaccines market in APAC 2015-2020 ($ millions) Exhibit 41: Impact of drivers and challenges on global travel vaccines market Exhibit 42: Impact of drivers Exhibit 43: A typical cold chain process Exhibit 44: Impact of drivers and challenges Exhibit 45: Impact of trends on global travel vaccines market Exhibit 46: Competitive structure analysis of global travel vaccines market 2015 Exhibit 47: Key vendors: Geographical presence 2015 Exhibit 48: Competitive assessment of vendors Exhibit 49: GlaxoSmithKline: Key highlights Exhibit 50: GlaxoSmithKline: Strength assessment Exhibit 51: GlaxoSmithKline: Strategy assessment Exhibit 52: GlaxoSmithKline: Opportunity assessment Exhibit 53: Merck: Key highlights Exhibit 54: Merck: Strength assessment Exhibit 55: Merck: Strategy assessment Exhibit 56: Merck: Opportunity assessment Exhibit 57: Pfizer: Key highlights Exhibit 58: Pfizer: Strength assessment Exhibit 59: Pfizer: Strategy assessment Exhibit 60: Pfizer: Opportunity assessment Exhibit 61: Sanofi: Key highlights Exhibit 62: Sanofi: Strength assessment Exhibit 63: Sanofi: Strategy assessment Exhibit 64: Sanofi: Opportunity assessment

GlaxoSmithKline, Merck, Pfizer, Sanofi, Abbott, AstraZeneca, Bavarian Nordic, Baxter, Beijing Minhai Biotechnology, Bharat Biotech, Bharat Immunologicals and Biologicals, Bio-Med, Seqirus CSL, Crucell, CSL, Dynavax Technologies, Emergent BioSolutions, GlycoVaxyn, GreenSignal Bio Pharma, Hualan Biological Engineering, Imunoloski Zavod, Indian Immunologicals, Janssen Pharmaceuticals, JN International Medical, Kaketsuken, LG Life Sciences, Lupin, Mitsubishi Tanabe Pharma, Novavax, Nuron Biotech, Panacea Biotec, Pfizer, Protein Sciences, Roche, SK Chemicals, Serum Institute of India, Shenzhen Kangtai Biological Products, Sinovac Biotech, Takeda Pharmaceutical, Vacunas Finlay, Valeant Pharmaceuticals, Valneva, Zydus Cadila.